Document is current
Any future updates will be listed below
-
Authors
Katagiri, Junko
Homma, Jun
Takagi, Ryo
Sekine, Hidekazu
Shinkawa, Takeshi
Niinami, Hiroshi
Shimizu, Tatsuya
- License Information
-
More Information
Article History
Received: 12 December 2024
Accepted: 16 May 2025
First Online: 28 May 2025
Declarations
:
: All animal experiments were approved by the Ethics Committee for Animal Experiments of Tokyo Women’s Medical University. Approved project title: Application of mesenchymal stem cells to a model of mitomycin C-induced pulmonary veno-occlusive disease. Approved number: AE23-120 and AE24-074, permitted on April 25, 2023.
: Not applicable.
: The authors declare the following financial interests/personal relationships that may be considered as potential competing interests: T.S. is a shareholder of CellSeed, Inc., and Tokyo Women’s Medical University received research funding from CellSeed, Inc. The other authors have no financial conflicts or competing interests to disclose.
